J Bruzzese - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

J Bruzzese

Showing results (21-30 of 26) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 26 results.

The Biochemical Journal|July 17, 2010

Characterization of a new series of non-covalent proteasome inhibitors with exquisite potency and selectivity for the 20S beta5-subunitChristopher Blackburn, Kenneth M Gigstad, Paul Hales, et al.

The Journal of Biological Chemistry|June 27, 2014

Mechanistic study of Uba5 enzyme and the Ufm1 conjugation pathwayJames M Gavin, Kara Hoar, Qing Xu, et al.

The Journal of Biological Chemistry|October 5, 2011

Mechanistic studies of substrate-assisted inhibition of ubiquitin-activating enzyme by adenosine sulfamate analoguesJesse J Chen, Christopher A Tsu, James M Gavin, et al.

Molecular Cancer Therapeutics|December 19, 2006

Comparison of biochemical and biological effects of ML858 (salinosporamide A) and bortezomibMark J Williamson, Jonathan L Blank, Frank J Bruzzese, et al.

Cancer Discovery|April 19, 2026

TNG961 is a selective oral HBS1L molecular glue degrader for the treatment of FOCAD-deleted cancersHilary E Nicholson, Douglas A Whittington, Frank J Bruzzese, et al.

Molecular Cell|February 5, 2010

Substrate-assisted inhibition of ubiquitin-like protein-activating enzymes: the NEDD8 E1 inhibitor MLN4924 forms a NEDD8-AMP mimetic in situJames E Brownell, Michael D Sintchak, James M Gavin, et al.

Pageof 3

Search research articles

Showing results (21-30 of 26) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 26 results.

The Biochemical Journal|July 17, 2010

Characterization of a new series of non-covalent proteasome inhibitors with exquisite potency and selectivity for the 20S beta5-subunitChristopher Blackburn, Kenneth M Gigstad, Paul Hales, et al.

The Journal of Biological Chemistry|June 27, 2014

Mechanistic study of Uba5 enzyme and the Ufm1 conjugation pathwayJames M Gavin, Kara Hoar, Qing Xu, et al.

The Journal of Biological Chemistry|October 5, 2011

Mechanistic studies of substrate-assisted inhibition of ubiquitin-activating enzyme by adenosine sulfamate analoguesJesse J Chen, Christopher A Tsu, James M Gavin, et al.

Molecular Cancer Therapeutics|December 19, 2006

Comparison of biochemical and biological effects of ML858 (salinosporamide A) and bortezomibMark J Williamson, Jonathan L Blank, Frank J Bruzzese, et al.

Cancer Discovery|April 19, 2026

TNG961 is a selective oral HBS1L molecular glue degrader for the treatment of FOCAD-deleted cancersHilary E Nicholson, Douglas A Whittington, Frank J Bruzzese, et al.

Molecular Cell|February 5, 2010

Substrate-assisted inhibition of ubiquitin-like protein-activating enzymes: the NEDD8 E1 inhibitor MLN4924 forms a NEDD8-AMP mimetic in situJames E Brownell, Michael D Sintchak, James M Gavin, et al.

Pageof 3